Maternal COVID-19 causing intrauterine foetal demise with microthrombotic placental insufficiency: a case report

BMC Pregnancy Childbirth. 2023 Sep 9;23(1):653. doi: 10.1186/s12884-023-05942-6.

Abstract

Background: Pregnant women have an increased risk of getting infected with SARS-CoV-2 and are more prone to severe illness. Data on foetal demise in affected pregnancies and its underlying aetiology is scarce and pathomechanisms remain largely unclear.

Case: Herein we present the case of a pregnant woman with COVID-19 and intrauterine foetal demise. She had no previous obstetric or gynaecological history, and presented with mild symptoms at 34 + 3 weeks and no signs of foetal distress. At 35 + 6 weeks intrauterine foetal death was diagnosed. In the placental histopathology evaluation, we found inter- and perivillous fibrin depositions including viral particles in areas of degraded placental anatomy without presence of viral entry receptors and SARS-CoV-2 infection of the placenta.

Conclusion: This case demonstrates that maternal SARS-CoV-2 infection in the third trimester may lead to an unfavourable outcome for the foetus due to placental fibrin deposition in maternal COVID-19 disease possibly via a thrombogenic microenvironment, even when the foetus itself is not infected.

Keywords: COVID-19; Case report; In situ detection; Intrauterine foetal death; Microthrombosis; Perivillous fibrin deposition and chronic placentitis; Pregnancy; SARS–CoV-2-Infection; Vertical transmission.

Publication types

  • Case Reports

MeSH terms

  • COVID-19* / complications
  • Female
  • Fibrin
  • Humans
  • Placenta
  • Placental Insufficiency* / etiology
  • Pregnancy
  • SARS-CoV-2
  • Stillbirth

Substances

  • Fibrin